From: A health economics study of long-acting injectable once-monthly paliperidone palmitate in schizophrenia: a one-year mirror-image study in China
Medicine costs
Hospitalization costs
Direct costs
pre-PP1M (¥)
8302 ± 4156
9155 ± 18816
17457 ± 17414
Post-PP1M (¥)
20121 ± 4580
2915 ± 8466
23030 ± 8648
Difference
142%
-68.15%
31.92%
P
< 0.01
0.074